Ian A. Pringle

Biochemistry, Genetics and Molecular Biology · Life Sciences

17h-index1.7kcitations71works0.32yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(25), RNA Interference and Gene Delivery(20), Neonatal Respiratory Health Research(17), Viral gastroenteritis research and epidemiology(13), Cystic Fibrosis Research Advances(10)

Publications71 total

TOWARDS SUSTAINABLE TWO-WHEELED TRANSPORT IN AUSTRALIA: AN ENVIRONMENTAL ASSESSMENT OF ELECTRIC MOTORCYCLES
Transport Problems·2025Open Access
Expected environmental implications of hydrogen fuel cell buses in Australia
International Journal of Sustainable Engineering·2024· 1 citedOpen Access
Long-Term Electric Vehicles Outlook in Australia: Environmental Benefits
International Journal on Energy Conversion (IRECON)·2024
Analysis and Prediction of Crash Fatalities in Australia
The Open Transportation Journal·2019· 15 citedOpen Access
Lentivirus Gene Therapy for Autoimmune Pulmonary Alveolar Proteinosis
Molecular Therapy·2019
T2 Lentivirus GM-CSF gene therapy ameliorates autoimmune pulmonary alveolar proteinosis
2018· 3 cited
The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins
Gene Therapy·2018· 13 citedOpen Access
Large-scale, high-throughput production of lentiviral vectors for multiple disease applications
Oxford University Research Archive (ORA) (University of Oxford)·2018Open Access
Lentivirus GM-CSF gene therapy for autoimmune pulmonary alveolar proteinosis
Oxford University Research Archive (ORA) (University of Oxford)·2018Open Access
Expression Profile of Optimised SIV Vector in the Mouse Lung at Early Timepoints Post-Delivery
Oxford University Research Archive (ORA) (University of Oxford)·2018Open Access
A method for assessing the distribution of eGFP expressing cells in the mouse lung following lentiviral vector transduction
Oxford University Research Archive (ORA) (University of Oxford)·2018Open Access
The lung as a factory to produce secreted intrapulmonary and circulatory proteins
Oxford University Research Archive (ORA) (University of Oxford)·2017Open Access
Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis
Thorax·2016· 141 citedOpen Access
Patient information sheets
2016
Dose preparation sheet
2016
Results of mechanistic substudy
2016
Methods: clinical trial design and outcome measures
2016
Safety and adverse events
2016· 1 cited
A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis
Efficacy and Mechanism Evaluation·2016· 45 citedOpen Access
Results of clinical efficacy outcomes
2016
page 1 of 4Next →

Frequent Co-authors

Stephen C. Hyde(43), Deborah R. Gill(36), Eric W.F.W. Alton(27), Uta Griesenbach(27), Stephanie Jones(24), Jane C. Davies(17), Lee A. Davies(17), Gerry McLachlan(16), Seng H. Cheng(15), Mario Chan(14), David J. Porteous(14), David Collie(13), Kamila M Pytel(13), J. Alastair Innes(12), Tracy Higgins(11), Ronald K. Scheule(11), Barbara Stevenson(11), Marguerite Y Wasowicz(11), Heather Davidson(10), Ann Doherty(10)